| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
RI, and IL-13 Are Required for Development of Airway Hyperresponsiveness after Aerosolized Allergen Exposure in the Absence of Adjuvant1
* Division of Cell Biology, Department of Pediatrics, National Jewish Medical and Research Center, Denver, CO 80206;
The Jackson Laboratory, Bar Harbor, ME 04609; and
Wyeth Institute, Cambridge, MA 02140
In certain models of allergic airway disease, mast cells facilitate the development of inflammation and airway hyper-responsiveness (AHR). To define the role of the high affinity IgE receptor (Fc
RI) in the development of AHR, mice with a disruption of the 
subunit of the high affinity IgE receptor (FcRI–/–) were exposed on 10 consecutive days to nebulized OVA. Forty-eight hours after the last nebulization, airway responsiveness was monitored by the contractile response of tracheal smooth muscle to electrical field stimulation (EFS). After the 10-day OVA challenge protocol, wild-type mice demonstrated increased responsiveness to EFS, whereas similarly challenged FcRI–/– mice showed a low response to EFS, similar to nonexposed animals. Further, allergen-challenged FcRI–/– mice showed less airway inflammation, goblet cell hyperplasia, and lower levels of IL-13 in lung homogenates compared with the controls. IL-13-deficient mice failed to develop an increased response to EFS or goblet cell hyperplasia after the 10-day OVA challenge. We transferred bone marrow-derived mast cells from wild-type mice to FcRI–/– mice 1 day before initiating the challenge protocol. After the 10-day OVA challenge, recipient FcRI–/– mice demonstrated EFS-induced responses similar to those of challenged wild-type mice. Transferred mast cells could be detected in tracheal preparations. These results show that FcRI is important for the development of AHR after an aerosolized allergen sensitization protocol and that this effect is mediated through FcRI on mast cells and production of IL-13 in the lung.
This article has been cited by other articles:
|
|
 |
|
  S. Matsubara, C. H. Swasey, J. E. Loader, A. Dakhama, A. Joetham, H. Ohnishi, A. Balhorn, N. Miyahara, K. Takeda, and E. W. Gelfand Estrogen Determines Sex Differences in Airway Responsiveness after Allergen Exposure Am. J. Respir. Cell Mol. Biol., May 1, 2008; 38(5): 501 - 508. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Reuter, A. Heinz, M. Sieren, R. Wiewrodt, E. W. Gelfand, M. Stassen, R. Buhl, and C. Taube Mast cell-derived tumour necrosis factor is essential for allergic airway disease Eur. Respir. J., April 1, 2008; 31(4): 773 - 782. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Katoh, N. Ishii, A. Nobumoto, K. Takeshita, S.-Y. Dai, R. Shinonaga, T. Niki, N. Nishi, A. Tominaga, A. Yamauchi, et al. Galectin-9 Inhibits CD44-Hyaluronan Interaction and Suppresses a Murine Model of Allergic Asthma Am. J. Respir. Crit. Care Med., July 1, 2007; 176(1): 27 - 35. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Brown, C. Taube, N. Miyahara, T. Koya, R. Pelanda, E. W. Gelfand, and R. M. Torres Arhgef1 Is Required by T Cells for the Development of Airway Hyperreactivity and Inflammation Am. J. Respir. Crit. Care Med., July 1, 2007; 176(1): 10 - 19. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Joetham, K. Takada, C. Taube, N. Miyahara, S. Matsubara, T. Koya, Y.-H. Rha, A. Dakhama, and E. W. Gelfand Naturally Occurring Lung CD4+CD25+ T Cell Regulation of Airway Allergic Responses Depends on IL-10 Induction of TGF-beta J. Immunol., February 1, 2007; 178(3): 1433 - 1442. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Wegmann, R. Goggel, S. Sel, S. Sel, K. J. Erb, F. Kalkbrenner, H. Renz, and H. Garn Effects of a Low-Molecular-Weight CCR-3 Antagonist on Chronic Experimental Asthma Am. J. Respir. Cell Mol. Biol., January 1, 2007; 36(1): 61 - 67. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kitamura, K. Takeda, T. Koya, N. Miyahara, T. Kodama, A. Dakhama, T. Takai, A. Hirano, M. Tanimoto, M. Harada, et al. Critical Role of the Fc Receptor {gamma}-Chain on APCs in the Development of Allergen-Induced Airway Hyperresponsiveness and Inflammation J. Immunol., January 1, 2007; 178(1): 480 - 488. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Klein, S. Klein-Hessling, A. Palmetshofer, E. Serfling, C. Tertilt, T. Bopp, V. Heib, M. Becker, C. Taube, H. Schild, et al. Specific and Redundant Roles for NFAT Transcription Factors in the Expression of Mast Cell-Derived Cytokines J. Immunol., November 15, 2006; 177(10): 6667 - 6674. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Abonia, J. Hallgren, T. Jones, T. Shi, Y. Xu, P. Koni, R. A. Flavell, J. A. Boyce, K. F. Austen, and M. F. Gurish Alpha-4 integrins and VCAM-1, but not MAdCAM-1, are essential for recruitment of mast cell progenitors to the inflamed lung Blood, September 1, 2006; 108(5): 1588 - 1594. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Taube, N. Miyahara, V. Ott, B. Swanson, K. Takeda, J. Loader, L. D. Shultz, A. M. Tager, A. D. Luster, A. Dakhama, et al. The Leukotriene B4 Receptor (BLT1) Is Required for Effector CD8+ T Cell-Mediated, Mast Cell-Dependent Airway Hyperresponsiveness. J. Immunol., March 1, 2006; 176(5): 3157 - 3164. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Matsubara, G. Li, K. Takeda, J. E. Loader, P. Pine, E. S. Masuda, N. Miyahara, S. Miyahara, J. J. Lucas, A. Dakhama, et al. Inhibition of Spleen Tyrosine Kinase Prevents Mast Cell Activation and Airway Hyperresponsiveness Am. J. Respir. Crit. Care Med., January 1, 2006; 173(1): 56 - 63. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Boyce and K. F. Austen No audible wheezing: nuggets and conundrums from mouse asthma models J. Exp. Med., June 20, 2005; 201(12): 1869 - 1873. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. D'Ambrosio, M. T. Cantorna, A. August, Y. Zhu, and M. Froicu Increased IgE but Reduced Th2-Type Inflammation in Vitamin D Receptor-Deficient Mice J. Immunol., April 15, 2005; 174(8): 4451 - 4451. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
